Dirk Thye - CEO and CMO, Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and CMO, Director
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dirk Thye since 11/29/2024

Holdings reported by Dirk Thye for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 995K $1.19M $1.20 Jun 18, 2025 Direct
Warrants 151K $18.9K $0.13 Jun 18, 2025 Direct Common Shares
Employee Stock Option (right to buy) 1.2M Jan 28, 2025 Direct Common Stock

Transactions reported by Dirk Thye for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.